In conclusion, the studies summarized in this mini review highlight the clinical relevance of contextual IGF1R expression during breast cancer tumorigenesis and emphasize the need for further research in order to more thoroughly define the mechanisms distinguishing IGF1Rhigh and IGF1Rlow tumors with the ultimate goal being more targeted and effective therapeutic strategies for patients. The gene discussed is IGF1R; the disease is breast cancer.